Guest guest Posted March 9, 2006 Report Share Posted March 9, 2006 President Clinton's Travel Diary on Visting India New Delhi, India, Diary Entry: February 18th,February 21st My HIV/AIDS Initiative has substantially reduced the prices nations participating in our procurement consortium pay for life-saving antiretroviral (ARV) treatments, but that's only the first step toward controlling the spread of HIV/AIDS in India. We also have to work on training health care professionals to cope with the pandemic. Today I visited New Delhi's All India Institute of Medical Sciences, where I talked to people living with HIV/AIDS and the health professionals who give them the care they need. While there, I announced a program through a partnership between my Foundation and the National AIDS Control Organization, to train thousands of nurses in AIDS care and treatment. Nurses play a vital role in the global struggle against HIV/AIDS. They deliver critical care, provide counseling about AIDS prevention, and help reduce the stigma and discrimination that many people living with the virus struggle to overcome. After the announcement I visited with patients at the All India Institute. As always, when I visit with patients, I was moved by their spirit, their optimism, and their courage and I was heartened by the fact that AIDS treatment drugs are keeping them alive. This is why our work is so important. I don't want to see anyone die before their time, and these people deserve a chance to live full, happy lives. ________________________________________ February 18, 2006 Goa, India Diary Entry: February 19th February 21st Last night I flew to Goa, India. A former Portuguese colony on the Arabian Sea, Goa is beautiful city flush with beaches and lush tropical forests. I'm here to tour a factory run by Cipla, an important partner in my Foundation's HIV/AIDS Initiative's work, and we had a great tour this morning and I saw a lot of what is really a world-class facility. Three years ago, we teamed up with Cipla and other drug makers to provide AIDS medication at affordable prices to people in the developing world. Today, because of partners like Cipla, we are able to provide life-saving antiretroviral drugs at prices reduced by 50 to 90 percent to people living with HIV/AIDS. When Cipla and my Foundation first started working together, only 70,000 people in the developing world (outside of Brazil and Thailand) were receiving these life-saving treatments. Now more than one million people take antiretroviral medication in developing countries, including over a quarter of a million people who get them under my Foundation's agreements. The AIDS medications produced at the Cipla factories provide hope for the 5.1 million people living in India with the virus -- but this is only the first step. When people start on antiretroviral medication, they're making a lifetime commitment. For long-term treatment to remain effective, many patients must eventually move from cheaper first-line antiretroviral drugs to much more costly second-line combinations. We have made progress in cutting the prices of these medications, but we still have a long way to go before they are available to all of those who need them. Sadly, despite all of our progress getting medication to those who need it, more remains to be done both throughout the developing world and especially right here in India. The UNAIDS predicts that between 2015 and 2050, nearly 50 million Indians will die of AIDS. Those are frightening numbers, but there is hope. Strong prevention and treatment programs can halt the spread of the pandemic here. That's why my Foundation signed an agreement with the Indian government to work together in the battle against HIV/AIDS. It won't be easy to overcome the challenges posed by the virus in India, but we can't afford to fail. With the help of companies like Cipla and proactive governments like India's, I'm confident that we will succeed. I'm headed to Delhi this evening to announce a nurse training program with the Indian government and to visit with some AIDS patients, so keep an eye out for my next post. Source: <enewsletter@...> Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.